GP Core Conditions Flashcards
Dx asthma
1) Gold standard
2) Others (X2)
1) Spirometry FEV1:FVC <0.7
2)
Clinical Dx- recurrence, wheeze, diurnal variation, Atopy in FHx
PEFR- Best of 3 within 40L/min; 2 readings/day for 2 weeks
Asthma annual review- what 4 things do you cover?
1) Symptom control- sleeping? Symptoms during day? Interference with activities and cotrico use/time off
2) Lung function- PEFR/Spiro if needed
3) Check inhaler function/Compliance
4) Asthma action plan- 2 cans of Salbutamol/Month is poor control- intensify therapy
Step wise treatment of chronic asthma (BTS guidelines)
~6 steps
1) Short acting B2 agonist
2) ICS- Beclometasone 200-800mg
3) + LABA (Salmetrol)
4) Increase ICS dose to max 800mg
5) Leukotriene R antagonist or sustained release theophylline
6) Referral, 4th drug? Inc ICS
What are 4 signs of poor asthma control; indicating escalation to ICS therapy from SABA?
1) 3+ Uses of SABA/week
2) Symptoms 3+ times/week
3) Waking >1 time a week
4) An exacerbation in the last 2 years
COPD- How are these signs/symptoms different in Emphysema and bronchitis?
1) SOB
2) Cyanosis
2) Weight loss
1) SOB early and severe in Emphysema
2) Bronchitis cyanosed
3) Emphysema more likely to have muscle wasting and significant weight loss
Role of spirometry in COPD?
FEV1/FVC?
1) Dx
2) Monitor progression w/ other factors
FEV1?FVC <0.7
Staging of COPD using FEV1- what are the stages?
% of predicted
1) >80%
2) 50-79%
3) 30-49%
4) < 30% (<50% + risk factors)
Comment on the uses of the below in COPD Dx
1) Reversibility testing
2) Key signs
3) Post-bronchodilator spirometry
4) FBC, BMI, CXR
1) Not needed; only useful if ?Asthma
2) Accessory muscle use, cricosternal distance <3cm, Dec sounds, no diurnal variation
3) Reconsider Dx if marked improvement in symptoms
4) PCV, Anaemia
Low
Exclude other Dx
In COPD what should happen to FEV1/FVC with inhaled therapy?
Should NOT normalise- NO reversibility
5 grades of the Medical Research council dyspnoea scale
Grade 1: not troubled by breathlessness except on strenuous exertion.
Grade 2: short of breath when hurrying on level ground or walking up a slight incline.
Grade 3: walks slower than contemporaries because of breathlessness, or has to stop for breath when walking at own pace.
Grade 4: stops for breath after walking about 100 metres or stops after a few minutes of walking on level ground.
Grade 5: too breathless to leave the house or breathless on dressing or undressing.
COPD management
1) What vaccine are needed? (2X)
2) Lifestyle advice
3) Criteria for Rehabilitation?
1) Pneumococcal/Influenza
2) Stop smoking, encourage mobility, Good diet to ameliorate Wx loss
3) MCP >/= 3 or symptoms infringe on QoL
Chronic COPD management
1) 1st line
2) The presence of what feature decides how you should escalate
3) 2nd Line
4) Triple therapy?
1) SABA or SAMA (Ipratropium)
2) Asthmatic features (PEFR/diurnal variation) as this indicates ICS responsiveness
3) No asthmatic features add LAMA (Tiotropium) Or LABA
Asthmatic features= LABA + ICS
4) LABA +LAMA + ICS
Chronic COPD management- What 2 drugs should you never use together?
SAMA and LAMA
ECG signs of AF
Irregularly irregular PR
Absent P waves
Indications for a transthoracic echo in AF?
Check for emboli before cadioversion
Suspicion of structural/functional abnormality
When is a transoesophageal Echo needed in AF?
After transthoracic shows an abnormality
Transthoracic technically difficult
TRO guided cardioversion
Treating chronic AF- RATE control
1) Monotherapy?
2) Intensification?
1) Beta blocker or diltiazem (CCB)
2) Combine the above or add digoxin
Treating chronic AF- RATE control
1) What specific type of AF is digoxin best for?
Non-paroxysmal and pt is sedentary
Treating chronic AF- RATE control
1) HR target?
2) What does this change to if symptomatic?
1) <90 (Consider <110)
2) <80
Treating chronic AF- Rhythm control
1) When is this indicated?
1) Symptomatic, young, 1st presentation with lone AF, rate control is inadequate
Treating Chronic AF- Rhythm control
1) 1st line for rhythm control
2) Alternatives to above
1) Beta blocker (CI if asthmatic!)
2) Dronedarone or Amiodarone
Treating chronic AF- Rhythm control
1) Indications for Dronedarone
1) Successful Cardioversion, Paroxysmal/persistent AF, if 1st line rhythm control fails, IHD/TIA/DM/HTN/>70
Treating chronic AF- Rhythm control
1) Why would you consider Amiodarone> Dronedarone
1) LV impairment or HF
Treating chronic AF- Pill in the pocket
1) Indications?
2) CI?
1) Known precipitants, infrequent attacks
2) LVD, VHD, IHD in PMHx
Treating chronic AF- Anticoagulation
1) What scoring systems do you use? (2)
2) What do they assess?
CHA2DS2- VAD- Stroke risk
HAS-BLED- Bleeding risk
Treating chronic AF- Anticoagulation
1) CHA2DS2- VAD score needed for anticoagulation
2) HAS-BLED score that indications caution
1) Males= 1 Females = 2
2) Greater than or equal to 3
Treating Acute AF- What is indicated when…
1) < 48hrs + Haemodynamic instability
2) < 48 hrs + stable
3) > 48 hours
1) Electric cardioversion
2) Consider managing as >48 hrs
3) Cardioversion (DC or flecoinide) +/- Amiodarone (stating 4 weeks before)
Most common duration of TIA symptoms?
10-15 mins
Must be less than 24 hours to be TIA
Different categories of symptoms to consider for TIA/Stroke
Motor Sensory Meningism Pain Speech Cognition Consciousness Sight
What global symptoms make TIA less likely as the aetiology?
Unsteadiness
Dizzy
Syncope
Key stroke mimics?
Hypoglycaemia Migraine Seziure Bell's palsy MS ?Sepsis
CT target if stroke likely?
1 hr
What anti-platelet is indicated, and for how long, in TIA
300mg aspirin for 14 days
then an assessment within 24hrs by a specialist
TIA secondary prevention?
Lifestyle- Smoking and alcohol reduction. Encourage exercise.
Atorvastatin 20-80mg
BP lowering if HTN
Anticoagulation ONLY if AF
Briefly outline acute stroke management
Exclude haemorrhage
<4.5 hours then alteplase
300mg Aspirin
75 mg Clopidogrel
Define CKD
Abnormal renal function for > 3months
Progressive and Irreversible
What are the metabolic complications of CKD?
Normochromic normocytic anaemia Renal osteodystrophy Renal dysfunction (Nocturia, polyuria, salt retention/oedema) Accelerated CVD Platelet abnormalities, skin pigmentation, Pruritis Hyperkalaemia Metabolic acidosis Neuropathy
What symptoms help differentiate CKD from AKI?
CKD more likely if Wx loss, anorexia, pruritis and nocturia
Could be an Acute-on-chronic presentation
4 key investigations of CKD
eGFR (Superior to creatinine and urea)
Proteinuria
Haematuria
Renal USS (Small echogenic kidneys)
How is proteinura useful for CKD?
Best way to detect this? GIVE VALUES!
Assessment and prognostic info (presence and quantity is a RF for progression)
Albumin:Creatinine ratio (ACR)
> 3mg/mmol is clinically significant
ACR in CKD
1) How do you measure ACR?
2) What value indicates no need to repeat? When do you repeat?
1) 24hr urine collection or morning urine
2) > 70 mg/mmol= no repeat needed as excessively high
3-70 then repeat
(Anything > 3 suggests CKD)
Best way to detect Haematuria in CKD?
What result warrants further evaluation?
Reagent strips not urine microscopy
Greater than or equal to 1+
Indications for a Renal USS in CKD?
Accelerated progression Haematuria Symptoms of obstruction GFR< 30 Polycystic KD in FHx
What are the eGFR values for the different stages of CKD?
1- > 90 NORMAL 2- 60-89 (Other evidence of CKD required) 3a- 45-59 (Moderate) 3b- 30-44 (Moderate) 4- 15- 29 (Severe) 5- <15 (Failure)
If the eGFR value is 60-90 in ?CKD what other evidence is required for a Dx?
Persistent microalbuminaemia/proteinuria/haematuria
Structural abnormalities
Biopsy proven glomerulonephritis
In CKD are the following likely to be raised or decreased? Na K Bicarb Alk Phos Ca Phos PTH Lipids
Na-Norm or Inc K- Inc Bicarb- Dec Alk Phos- Increased indicating bone disease Ca- ANY Phos- inc PTH- Inc with progressively declining function Lipids- Dyslipidaemia is commonn
3 key RF for CKD progression
1) Uncontrolled BP
2) Advanced stage/ Declining eGFR
3) Proteinuria
BP target in CKD if HTN?
What factors reduce this further and to what level?
Typically < 140/90
If DM or ACR of 70mg/mmol then <130/80